Anne Sophie Sølling

9PUBLICATIONS
8CO-AUTHORS
OrthopticsEndodonticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 17, 2025
Approach to the Patient - Transitions in Osteoporosis Therapy.

Bente L Langdahl, Natasha A Laursen, Vivi Mäkinen

|Dec 23, 2022
Denosumab Discontinuation.

Anne Sophie Sølling, Elena Tsourdi, Torben Harsløf

|Dec 21, 2022
Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption.

Anne Sophie Sølling, Torben Harsløf, Niklas Rye Jørgensen

|Nov 19, 2022
Discontinuation of denosumab in men with prostate cancer.

Anne Sophie Sølling, Torben Harsløf, Helle Kongsbak Brockstedt

|Apr 04, 2021
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis: A 2-Year Randomized Study.

Anne Sophie Sølling, Torben Harsløf, Bente Langdahl

|Jan 31, 2021
The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study.

A S Sølling, T Harsløf, N H Bruun

Pageof 2

Frequent Collaborators

8 joint publications

Torben Harsløf

8 joint publications

Bente Langdahl

1 joint publications

D H Christensen

1 joint publications

R W Thomsen